- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.55 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x K: POTASSIUM ION(Non-covalent)
- 2 x AMZ: AMINOIMIDAZOLE 4-CARBOXAMIDE RIBONUCLEOTIDE(Non-covalent)
AMZ.2: 15 residues within 4Å:- Chain A: N.431, R.451, A.540, F.541, R.588, F.590
- Chain B: R.207, Y.208, I.238, N.239, K.266, H.267, G.316, D.339
- Ligands: 354.3
17 PLIP interactions:8 interactions with chain B, 9 interactions with chain A- Hydrogen bonds: B:N.239, B:D.339, B:D.339, A:N.431, A:N.431, A:R.451, A:F.541, A:F.541
- Water bridges: B:R.207, B:R.207, B:I.238, B:N.239, A:R.588, A:R.588
- Salt bridges: B:R.207, A:R.588
- pi-Stacking: A:F.590
AMZ.6: 15 residues within 4Å:- Chain A: R.207, Y.208, I.238, N.239, K.266, H.267, G.316, D.339
- Chain B: N.431, R.451, A.540, F.541, R.588, F.590
- Ligands: 354.7
17 PLIP interactions:10 interactions with chain A, 7 interactions with chain B- Hydrogen bonds: A:Y.208, A:N.239, A:H.267, A:D.339, B:N.431, B:R.451, B:F.541, B:F.541
- Water bridges: A:R.207, A:R.207, A:R.207, A:R.207, A:I.238, B:R.588
- Salt bridges: A:R.207, B:R.588
- pi-Stacking: B:F.590
- 2 x 354: N-[(S)-(4-{[(2-AMINO-4-HYDROXYQUINAZOLIN-6-YL)(DIHYDROXY)-LAMBDA~4~-SULFANYL]AMINO}PHENYL)(HYDROXY)METHYL]-L-GLUTAMIC ACID(Non-covalent)
354.3: 20 residues within 4Å:- Chain A: N.431, Q.449, S.450, R.451, I.452, F.541, P.543, F.544, D.546, N.547, G.564, S.565, A.566
- Chain B: K.266, M.312, F.315, G.316, V.337, N.489
- Ligands: AMZ.2
18 PLIP interactions:10 interactions with chain A, 8 interactions with chain B- Hydrophobic interactions: A:R.451, A:F.541, A:P.543, A:P.543, B:F.315, B:F.315, B:F.315
- Hydrogen bonds: A:N.431, A:R.451, A:I.452, A:N.547, A:A.566, B:K.266, B:K.266, B:N.489
- Salt bridges: A:D.546
- Water bridges: B:N.489
- pi-Stacking: B:F.315
354.7: 17 residues within 4Å:- Chain A: K.266, M.312, F.315, N.489
- Chain B: N.431, Q.449, S.450, R.451, I.452, F.541, P.543, F.544, D.546, N.547, S.565, A.566
- Ligands: AMZ.6
15 PLIP interactions:9 interactions with chain B, 6 interactions with chain A- Hydrophobic interactions: B:R.451, B:P.543, A:F.315, A:F.315
- Hydrogen bonds: B:N.431, B:R.451, B:I.452, B:N.547, B:A.566, A:K.266, A:K.266
- Water bridges: B:D.546, A:N.489
- Salt bridges: B:D.546
- pi-Stacking: A:F.315
- 1 x XMP: XANTHOSINE-5'-MONOPHOSPHATE(Non-covalent)
XMP.4: 22 residues within 4Å:- Chain A: S.10, V.11, S.12, K.14, S.34, G.35, G.36, T.37, G.63, R.64, V.65, K.66, T.67, L.68, C.101, N.102, L.103, Y.104, D.125, I.126, G.127, G.128
20 PLIP interactions:19 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:S.12, A:S.34, A:G.36, A:T.37, A:R.64, A:K.66, A:K.66, A:T.67, A:L.68, A:Y.104, A:D.125, A:D.125, A:I.126, A:G.127, A:G.128, B:K.137
- Water bridges: A:K.66
- Salt bridges: A:K.14, A:K.66
- pi-Cation interactions: A:K.66
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cheong, C.-G. et al., Crystal structures of human bifunctional enzyme aminoimidazole-4-carboxamide ribonucleotide transformylase/IMP cyclohydrolase in complex with potent sulfonyl-containing antifolates. J.Biol.Chem. (2004)
- Release Date
- 2004-03-30
- Peptides
- Bifunctional purine biosynthesis protein PURH: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.55 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x K: POTASSIUM ION(Non-covalent)
- 2 x AMZ: AMINOIMIDAZOLE 4-CARBOXAMIDE RIBONUCLEOTIDE(Non-covalent)
- 2 x 354: N-[(S)-(4-{[(2-AMINO-4-HYDROXYQUINAZOLIN-6-YL)(DIHYDROXY)-LAMBDA~4~-SULFANYL]AMINO}PHENYL)(HYDROXY)METHYL]-L-GLUTAMIC ACID(Non-covalent)
- 1 x XMP: XANTHOSINE-5'-MONOPHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cheong, C.-G. et al., Crystal structures of human bifunctional enzyme aminoimidazole-4-carboxamide ribonucleotide transformylase/IMP cyclohydrolase in complex with potent sulfonyl-containing antifolates. J.Biol.Chem. (2004)
- Release Date
- 2004-03-30
- Peptides
- Bifunctional purine biosynthesis protein PURH: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B